Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis

被引:63
|
作者
Sano, Hitoshi [1 ]
Nakazawa, Takahiro [1 ]
Ando, Tomoaki [1 ]
Hayashi, Kazuki [1 ]
Naitoh, Itaru [1 ]
Okumura, Fumihiro [1 ]
Miyabe, Katsuyuki [1 ]
Yoshida, Michihiro [1 ]
Takahashi, Satoru [2 ]
Ohara, Hirotaka [3 ]
Joh, Takashi [1 ]
机构
[1] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Dept Expt Pathol & Tumor Biol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan
[3] Nagoya City Univ, Dept Community Based Med Educ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan
关键词
IBD; Inflammatory bowel disease; Primary sclerosing cholangitis; PSC; Ulcerative colitis; ULCERATIVE-COLITIS; AUTOIMMUNE PANCREATITIS; INDETERMINATE COLITIS; NATURAL-HISTORY; CROHNS-DISEASE; RISK; SPECTRUM; CANCER; JAPAN; ACID;
D O I
10.1007/s00534-010-0319-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Only a few studies have documented the characteristics of inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC). We aimed to clarify the clinical and histopathological characteristics of IBD associated with PSC (PSC-IBD). Twenty-nine patients with PSC and 60 patients with ulcerative colitis (UC) but without complicating PSC were enrolled in this study. First, the age and sex distribution, affected area, clinical course, number of recurrent attacks, and severity of UC were investigated. Then, mucosal specimens obtained from the right side (cecum and ascending colon), transverse colon, and the left side (descending colon, sigmoid colon, and rectum) during colonoscopy were studied for inflammatory cell infiltration, the presence of crypt abscesses, the degree of goblet cell disappearance, and edema. (1) The incidence of IBD in PSC patients was 68.9% (20/29). There were two peaks in the age distribution of PSC. Male PSC patients demonstrated a first peak and female patients a second peak. Male PSC-IBD patients were in their teens and 20s making the first peak. Female PSC-IBD patients were in their 50s and 60s making the second peak. The PSC-IBD patents were significantly younger than the patients without IBD (33.6 vs. 58.9 years, p < 0.001). (2) PSC-IBD showed a right-sided predominance colonoscopically. (3) None of the patients had a severe clinical course, and a half of them were asymptomatic. (4) Histopathological examination demonstrated severe inflammatory cell infiltration in the cecum and ascending colon, whereas the degree was mild in the rectum/descending colon. PSC-IBD shows characteristic clinical, colonoscopic, and histopathological findings.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
  • [21] Cholestyramine Treats Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease
    Pavlidis, Polychronis
    Heneghan, Michael
    Hayee, Bu'Hussain
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (02): : 210 - 210
  • [22] Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
    Sokol, Harry
    Cosnes, Jacques
    Chazouilleres, Olivier
    Beaugerie, Laurent
    Tiret, Emmanuel
    Poupon, Raoul
    Seksik, Philippe
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (22) : 3497 - 3503
  • [23] SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL-DISEASE
    FREESE, D
    LATIMER, JS
    GILBERSTADT, S
    KANE, W
    SHARP, HL
    CLINICAL PEDIATRICS, 1982, 21 (01) : 11 - 16
  • [24] The clinical course after liver transplantation for primary sclerosing cholangitis in patients with associated inflammatory bowel disease
    van de Vrie, W
    de Man, RA
    van Buuren, HR
    Dees, J
    Ijzermans, JNM
    Tilanus, HW
    Metselaar, HJ
    JOURNAL OF HEPATOLOGY, 2000, 32 : 57 - 57
  • [25] Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
    Guerra, Ivan
    Bujanda, Luis
    Castro, Jesus
    Merino, Olga
    Tosca, Joan
    Camps, Blau
    Gutierrez, Ana
    Gordillo Abalos, Jordi
    de Castro, Luisa
    Iborra, Marisa
    Carbajo, Ana Y.
    Taxonera, Carlos
    Rodriguez-Lago, Iago
    Mesonero, Francisco
    de Francisco, Ruth
    Gomez-Gomez, Gonzalo J.
    Chaparro, Maria
    Tardillo, Carlos A.
    Rivero, Montserrat
    Algaba, Alicia
    Martin Arranz, Eduardo
    Canete, Fiorella
    Vicente, Raquel
    Sicilia, Beatriz
    Antolin, Beatriz
    Prieto, Vanessa
    Marquez, Lucia
    Benitez, Jose M.
    Camo, Patricia
    Piqueras, Marta
    Gargallo, Carla J.
    Hinojosa, Esther
    Huguet, Jose M.
    Perez Calle, Jose L.
    Van Domselaar, Manuel
    Rodriguez, Cristina
    Calvet, Xavier
    Munoz-Villafranca, Carmen
    Garcia-Sepulcre, Mariana F.
    Munoz-Garrido, Patricia
    Fernandez-Clotet, Agnes
    Gomez Irwin, Laura
    Hernandez, Sherly
    Guardiola, Jordi
    Sempere, Laura
    Gonzalez Munoza, Carlos
    Hernandez, Vicent
    Beltran, Belen
    Barrio, Jesus
    Alba, Cristina
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (12): : 1492 - 1500
  • [26] RELATIONSHIP OF INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
    FAUSA, O
    SCHRUMPF, E
    ELGJO, K
    SEMINARS IN LIVER DISEASE, 1991, 11 (01) : 31 - 39
  • [27] Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer
    Broome, Ulrika
    Bergquist, Annika
    SEMINARS IN LIVER DISEASE, 2006, 26 (01) : 31 - 41
  • [28] Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis
    de Vries, A. Boudewijn
    Janse, Marcel
    Blokzijl, Hans
    Weersma, Rinse K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1956 - 1971
  • [29] Primary sclerosing cholangitis and inflammatory bowel disease: Where is the link?
    Qin, Xiaofa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (06): : 1332 - 1333
  • [30] Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis
    Van de Vrie, W
    de Man, RA
    van Buuren, HR
    Schouten, WR
    Tilanus, HW
    Metselaar, HJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) : 657 - 663